Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study

Noelle Frey; Jun Ho Jang; Jeff Szer; Arpad Illes; Hee-Je Kim; Ron Ram; Beng H Chong; Jacob M Rowe; Elena Borisenkova; Jane Liesveld; Eric S Winer; Azzeddine Cherfi; Vassilios Aslanis; Farhat Ghaznawi; Stephen Strickland

Journal article

Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study

Noelle Frey, Jun Ho Jang, Jeff Szer, Arpad Illes, Hee-Je Kim, Ron Ram, Beng H Chong, Jacob M Rowe, Elena Borisenkova, Jane Liesveld, Eric S Winer, Azzeddine Cherfi, Vassilios Aslanis, Farhat Ghaznawi, Stephen Strickland

The Lancet Haematology | ELSEVIER SCI LTD | Published : 2019

DOI: 10.1016/S2352-3026(18)30231-X

University of Melbourne Researchers

Jeffrey Szer Author Medicine - Royal Melbourne Hospital

Grants

Funding Acknowledgements

This study was funded by Novartis Pharma AG. We thank all the patients and co-investigators for their participation and contribution to this study. We thank Rebecca Helson of Mudskipper Business Ltd for medical editorial assistance. Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals Corporation.